Patents by Inventor Corrie GALLANT-BEHM

Corrie GALLANT-BEHM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MIR-29 MIMICS AND USES THEREOF
    Publication number: 20190127734
    Abstract: The present invention relates to synthetic oligonucleotide mimetics of miRNAs. In particular, the present invention provides double-stranded, chemically-modified oligonucleotide mimetics of miR-29. Pharmaceutical compositions comprising the mimetics and their use in treating or preventing conditions associated with dysregulation of extracellular matrix genes, such as tissue fibrotic conditions, are also described.
    Type: Application
    Filed: June 7, 2018
    Publication date: May 2, 2019
    Inventors: Rusty L. Montgomery, Christina M. Dalby, Eva Van Rooij, Corrie Gallant-Behm
  • miR-29 mimics and uses thereof
    Patent number: 9994847
    Abstract: The present invention relates to synthetic oligonucleotide mimetics of miRNAs. In particular, the present invention provides double-stranded, chemically-modified oligonucleotide mimetics of miR-29. Pharmaceutical compositions comprising the mimetics and their use in treating or preventing conditions associated with dysregulation of extracellular matrix genes, such as tissue fibrotic conditions, are also described.
    Type: Grant
    Filed: June 7, 2016
    Date of Patent: June 12, 2018
    Assignee: MIRAGEN THERAPEUTICS, INC.
    Inventors: Rusty L. Montgomery, Christina M. Dalby, Eva Van Rooij, Corrie Gallant-Behm
  • miR-29 Mimics and Uses Thereof
    Publication number: 20160355815
    Abstract: The present invention relates to synthetic oligonucleotide mimetics of miRNAs. In particular, the present invention provides double-stranded, chemically-modified oligonucleotide mimetics of miR-29. Pharmaceutical compositions comprising the mimetics and their use in treating or preventing conditions associated with dysregulation of extracellular matrix genes, such as tissue fibrotic conditions, are also described.
    Type: Application
    Filed: June 7, 2016
    Publication date: December 8, 2016
    Inventors: Rusty L. MONTGOMERY, Christina M. DALBY, Eva VAN ROOIJ, Corrie GALLANT-BEHM
  • miR-29 mimics and uses thereof
    Patent number: 9376681
    Abstract: The present invention relates to synthetic oligonucleotide mimetics of miRNAs. In particular, the present invention provides double-stranded, chemically-modified oligonucleotide mimetics of miR-29. Pharmaceutical compositions comprising the mimetics and their use in treating or preventing conditions associated with dysregulation of extracellular matrix genes, such as tissue fibrotic conditions, are also described.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: June 28, 2016
    Assignee: miRagen Therapeutics, Inc.
    Inventors: Rusty L. Montgomery, Christina M. Dalby, Eva Van Rooij, Corrie Gallant-Behm
  • miR-29 Mimics and Uses Thereof
    Publication number: 20160068842
    Abstract: The present invention relates to synthetic oligonucleotide mimetics of miRNAs. In particular, the present invention provides double-stranded, chemically-modified oligonucleotide mimetics of miR-29. Pharmaceutical compositions comprising the mimetics and their use in treating or preventing conditions associated with dysregulation of extracellular matrix genes, such as tissue fibrotic conditions, are also described.
    Type: Application
    Filed: September 8, 2015
    Publication date: March 10, 2016
    Inventors: Rusty L. MONTGOMERY, Christina M. DALBY, Eva VAN ROOIJ, Corrie GALLANT-BEHM